Creighton Friend

Medical Science Liaison, Oncology & Hematology @Johnson & Johnson

Washington, DC, US

Served as Communications Lead for a 65-member hematology MSL team, standardizing field communications and synthesizing scientific priorities across compounds• Led Johnson & Johnson’s strategic presence at the ALLIANCE Cooperative Group Congress, coordinating MSL engagement and aligning cross-functional stakeholders• Supported five hematologic oncology compounds (Carvykti, Darzalex-Faspro, Tecvayli, Talvey, Imbruvica) across launch readiness, indication expansion, and lifecycle management• Built and maintained collaborative, peer-level relationships with academic and community KOLs, investigators, and multidisciplinary HCPs to drive scientific exchange and insight generation• Integrated actionable field insights into internal strategy, helping shape evidence generation, publication planning, and access-related initiatives• Provided clinical trial support across site feasibility, startup, recruitment optimization, and protocol refinement in alignment with corporate and investigator goals• Delivered tailored scientific education on disease state, mechanism of action, and safety/efficacy data to support appropriate use of approved therapies• Ensured compliance with all applicable regulatory, legal, and ethical standards in the exchange of clinical and scientific information (FDA, ICH-GCP, OIG, PhRMA)

Virginia Commonwealth University

Doctor of Philosophy - PhD

Virginia Polytechnic Institute and State University

Biochemistry B.S., Nanoscience B.S., Microbiology B.S.